Onxeo — Capital/Financing Update 2024

Aug 5, 2024

Public limited company with a capital of € 21,610,998.20 Registered office: 49 boulevard du Général Martial Valin - 75015 Paris 410 910 095 R.C.S. on the Paris Trade and Companies Register

Half-year liquidity contract statement for Valerio Therapeutics

Paris, August 5, 2024, 7 PM CEST

Under the liquidity contract entered into between VALERIO THERAPEUTICS and Kepler Cheuvreux, the following resources appeared on the liquidity account on June 30, 2024:

• 392,365 shares
• € 144,905.34
• Number of executions on buy side on semester: 108
• Number of executions on sell side on semester: 95
• Traded volume on buy side on semester: 128,013 shares for € 15,133.69
• Traded volume on sell side on semester: 103,822 shares for € 12,955.33

As a reminder:

• the following resources appeared on the last half year statement on 31 December 2023 on the liquidity account:

• 368,174 shares
• € 144,918.05
• Number of executions on buy side on semester: 324
• Number of executions on sell side on semester: 244
• Traded volume on buy side on semester: 304,205 shares for € 69,976.87
• Traded volume on sell side on semester: 223,191 shares for € 56,117.81
• the following resources appeared on the liquidity account when the activity started:
• 87,612 shares
• € 196,423.24

The implementation of this report is carried out in accordance with AMF Decision N°2021-01 of June 22, 2021 renewing the implementation of liquidity contracts for shares as an accepted market practice.

Contacts

Valerio Therapeutics Investor Relations investors@valeriotx.com tel : +33 (0) 1 70 38 33 99